Novartis Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 9,769.0 | 9,210.0 | 8,710.0 |
| Net Investing Cash Flow | (10,367.0) | (6,244.0) | (6,575.0) |
| Net Financing Cash Flow | (2,573.0) | (9,318.0) | (4,970.0) |
| Net Change in Cash | (3,322.0) | 1,545.0 | (2,506.0) |
| Depreciation & Amortization | -- | -- | 2,026.0 |
| Capital Expenditures | (2,106.0) | (2,549.0) | (1,802.0) |
| Cash Dividends Paid | (3,395.0) | (2,638.0) | (2,084.0) |
© 2009 Morningstar, Inc. Financial Data provided by
